Latest Biosimilar Stories
GIA announces the release of a comprehensive global report on Human Growth Hormone Drugs markets.
RnRMarketResearch.com adds "Next-Generation Biologics R&D, Industry and Market 2014-2024" on its store.
- Terms Unchanged from Previously Disclosed Agreement - DUBLIN, June 9, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that it has finalized its previously announced
Margaret E. Kruk of Columbia University and co-authors assessed the effectiveness of Saving Mothers, Giving Life, a new global public-private partnership that aims to reduce maternal mortality in eight districts in Uganda and Zambia.
REDWOOD CITY, Calif., June 9, 2014 /PRNewswire/ -- Coherus BioSciences, Inc. ("Coherus"), is pleased to announce the appointment
WASHINGTON, June 4, 2014 /PRNewswire-USNewswire/ -- In a letter submitted today to the U.S.
Regulating Biosimilars; Stem Cell Therapies and 3-D Printing; Increasing FDA Oversight Overseas Washington (PRWEB) June 03, 2014 Hot topics facing drug
CRANBURY, N.J., June 2, 2014 /PRNewswire/ -- Ipca Laboratories Ltd., India (Ipca) and Oncobiologics, Inc., USA (Oncobiologics) announced today the creation of a two-part alliance for the
In an upcoming webinar from Atlantic Information Services, participants will learn how to manage specialty drug coupons without compromising patient access. Washington,
New research report “The Future of Biosimilars: mapping critical uncertainties and the impact of future events” by FirstWord is now available at MarketPublishers.com. London,
- The act of sweetening by admixture of some saccharine substance.